BOZEN, Italy, March 25 /PRNewswire/ -- Health Robotics today announced the early release in the second half of 2009 of its i.v.STATION Profile option with a presentation [P13] at the Dubai International Pharmaceuticals and Technologies Conference and Exhibition (DUPHAT) http://www.duphat.ae/parallelSession.php on March 31, 2009 by Gaspar DeViedma, along with related booth exhibitions.
This i.v.STATION Profile option [at no additional cost] was originally scheduled to be released in 2010, and to be concurrently timed with non-American hospitals that demanded secure [biometric-ID] nurse-station-based access to IV Medications prescribed for a given patient’s electronic medical record [patient-specific]. This i.v.STATION Profile option works similarly to Profile options of existing Medication Dispensing Cabinets from multiple vendors [Pyxis, Omnicell, McKesson, Amerisource Bergen, etc.] routinely utilized for dispensing Oral Medications and Not-Ready-to-Administer Vials in nurse stations [wards] around the world.
During the pre-installation meetings recently conducted by i.v.STATION architects’ Paolo Giribona and Gaspar DeViedma with the 8 American customers scheduled to install i.v.STATION in Summer/Fall of 2009, it became evident that at least some of our American customers desired to join their non-American counterparts in complementing the use of i.v.STATION’s central pharmacy compounding with i.v.STATION’s distributed compounding at selected patients’ locations that lacked pharmacists’ physical presence on a 24/7 basis. Consequently, Health Robotics has decided to release the i.v.STATION Profile option six to twelve months early.
“Our plan is to start an i.v.STATION Profile beta implementation in one of our Adult Intensive Care Units. We expect that having this type of technology near the point-of-care will improve turn-around-time issues and will provide immediate life-critical coverage where our pharmacists cannot be physically present on a 24/7 basis. We expect that the i.v.STATION Profile Robot will deliver IV Medications to our Nursing staff, after they have been safely reviewed and approved remotely by our staff pharmacists, including an audit trail of all i.v.STATION Profile compounding steps and a digital picture review of the medication vials utilized in the compounding process”, said Scott Evans, Pharm.D., Chief Operating Officer, USC University Hospital and USC Norris Cancer Hospital.
i.v.STATION represents a revolutionary approach in the quest for safe, accurate, efficient, cost effective, and ready-to-administer IV Admixtures. Constructed around a scalable, distributed, and fail-safe architecture, i.v.STATION offers unprecedented final container flexibility, life-critical patient safety, and robotic precision and performance. i.v.STATION may be deployed in a variety of locations, including central and satellite pharmacies and direct patient care areas, due to its self-contained form, ISO Class 5 environment, and small “foot print”. Pharmacies may, for the first time, choose a robotic configuration that suits their needs, rather than being forced into the dated alternative of “one-size-fits-all, million-dollar-plus” robots. Whether a Pharmacy chooses a single or multiple i.v.STATION configurations, it will benefit from fully automated compounding while producing its ready-to-administer IV doses in a variety of syringe, bag, vial, and tamper-evident caps from diverse medical suppliers such as Baxter, B.Braun, Beckton Dickinson, Hospira, IMF, Covidien, and Terumo. i.v.STATION also supports “just-in-time IV filling” to reduce urgent turn-around-time issues of life-critical patients while avoiding premium prices associated with pre-filled bags and syringes and high cost CST devices, which are made obsolete by the i.v.STATION technology.
“While some competitors are entering the fifth annual delay in five years, halting all installations and manufacturing for at least a year in order to re-design their robots, and withdrawing products and features from their web sites, Health Robotics keeps demonstrating on-time and on-budget deliveries to customers worldwide and proving to the market that the future of safe, sterile, and ready-to-administer IV Medications is already a reality. There is no longer a need to wait to see if decade-long promises will be fulfilled”, stated Werner Rainer, Health Robotics’ CEO.
About Health Robotics:
Health Robotics is the global leading supplier of life-critical intra-venous medication preparation, compounding, and dispensing Robots, with forty-five-times more units sold that all of its competitors combined, and providing healthcare facilities in four continents with robotics technology and software automation solutions. The world-leading solutions CytoCare [hazardous IVs] and i.v.STATION [non-hazardous IVs] have and will greatly contribute to ease global hospitals’ and clinics’ growing pressures to improve patient safety through the effective and efficient production of sterile, accurate, and ready-to-administer IVs, to eliminate life-threatening drug-exchange errors, to decrease other medication errors and contamination risks, and to work more efficiently, increase throughput, reduce waste, and contain costs.
CONTACT: For additional information, please contact: Health Robotics,
Gaspar G. DeViedma, Altmanstrasse 9A, Bozen, Sud-Tyrol, I-39100, USA:
+1-609-980-7976, EUROPE: +39-346-963-4934,
gaspar.deviedma@health-robotics.com .
